Name: Bristol-Myers Squibb Co. (NYSE:BMY) | Balance Sheet: Assets (Quarterly)
Creator: Stock Analysis on Net

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Bristol-Myers Squibb Co., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash and cash equivalents	8,722)	9,574)	10,209)	15,726)	12,599)	10,875)	10,346)	7,890)	6,293)	9,330)	11,464)	7,514)	8,372)	8,995)	9,123)	7,734)	10,750)	12,369)	13,979)	13,540)	11,024)	10,982)
Marketable debt securities	2,345)	912)	464)	776)	1,004)	907)	513)	204)	360)	340)	816)	171)	358)	274)	130)	1,293)	2,478)	2,599)	2,987)	2,123)	1,946)	1,948)
Receivables	10,553)	9,368)	11,414)	11,422)	11,415)	10,801)	10,747)	11,026)	11,423)	10,447)	10,921)	10,304)	10,112)	10,054)	9,886)	9,613)	9,054)	8,511)	9,369)	9,245)	9,017)	8,660)
Inventories	2,737)	2,756)	2,690)	2,758)	2,737)	2,666)	2,557)	3,332)	3,077)	2,985)	2,662)	2,436)	2,364)	2,605)	2,339)	2,074)	2,142)	2,104)	2,095)	2,163)	2,137)	1,953)
Other current assets	4,222)	4,598)	4,613)	4,948)	5,467)	5,534)	5,617)	5,623)	5,737)	5,567)	5,907)	7,207)	6,868)	5,158)	5,795)	6,082)	5,762)	4,538)	4,832)	4,372)	5,037)	3,568)
Current assets	28,579)	27,208)	29,390)	35,630)	33,222)	30,783)	29,780)	28,075)	26,890)	28,669)	31,770)	27,632)	28,074)	27,086)	27,273)	26,796)	30,186)	30,121)	33,262)	31,443)	29,161)	27,111)
Property, plant and equipment	7,791)	7,658)	7,543)	7,349)	7,373)	7,213)	7,136)	6,903)	6,845)	6,750)	6,646)	6,481)	6,355)	6,279)	6,255)	6,035)	5,970)	6,047)	6,049)	5,868)	5,795)	5,763)
Goodwill	21,740)	21,740)	21,754)	21,745)	21,776)	21,737)	21,719)	21,751)	21,732)	21,738)	21,169)	21,147)	21,163)	21,162)	21,149)	21,112)	20,446)	20,500)	20,502)	20,519)	20,529)	20,524)
Other intangible assets	17,387)	18,244)	19,103)	20,465)	21,378)	22,486)	23,307)	26,964)	29,428)	32,760)	27,072)	28,950)	31,303)	33,569)	35,859)	38,179)	37,690)	40,103)	42,527)	44,930)	48,065)	50,819)
Deferred income taxes	5,362)	5,176)	5,378)	4,961)	4,647)	3,997)	4,236)	3,609)	3,323)	2,723)	2,768)	1,514)	1,572)	1,317)	1,344)	1,329)	1,337)	1,418)	1,439)	684)	650)	793)
Marketable debt securities	397)	366)	396)	406)	346)	344)	320)	324)	357)	367)	364)	325)	—)	—)	—)	—)	—)	—)	—)	46)	143)	288)
Other non-current assets	6,378)	6,084)	6,474)	6,333)	5,934)	5,867)	6,105)	6,044)	6,071)	6,024)	5,370)	5,214)	5,022)	4,868)	4,940)	4,745)	4,728)	4,845)	5,535)	7,403)	6,454)	7,137)
Non-current assets	59,055)	59,268)	60,648)	61,259)	61,454)	61,644)	62,823)	65,595)	67,756)	70,362)	63,389)	63,631)	65,415)	67,195)	69,547)	71,400)	70,171)	72,913)	76,052)	79,450)	81,636)	85,324)
Total assets	87,634)	86,476)	90,038)	96,889)	94,676)	92,427)	92,603)	93,670)	94,646)	99,031)	95,159)	91,263)	93,489)	94,281)	96,820)	98,196)	100,357)	103,034)	109,314)	110,893)	110,797)	112,435)

Total assets exhibit a long-term downward trajectory, declining from 112,435 million USD in March 2021 to 87,634 million USD by June 2026. This contraction is primarily driven by a significant reduction in non-current assets, while current assets have remained relatively resilient, showing periods of growth and volatility throughout the analyzed timeframe.

Liquidity and Current Asset Trends: Cash and cash equivalents demonstrate significant volatility, characterized by a dip to 6,293 million USD in March 2024 followed by a peak of 15,726 million USD in September 2025, before settling at 8,722 million USD by June 2026. Receivables show a general upward trend, increasing from 8,660 million USD in March 2021 to a high of 11,422 million USD in September 2025, indicating an expansion in credit sales or changes in collection cycles. Inventories have also grown steadily, rising from 1,953 million USD at the start of the period to 2,737 million USD by the end of the period.
Non-Current Asset Erosion: The most substantial decline is observed in other intangible assets, which plummeted from 50,819 million USD in March 2021 to 17,387 million USD by June 2026. This suggests a systematic amortization of intangible assets over time. In contrast, goodwill has remained remarkably stable, fluctuating slightly between 20,446 million USD and 21,754 million USD, indicating a lack of significant impairment charges. Property, plant, and equipment (PPE) show a consistent and gradual increase, growing from 5,763 million USD to 7,791 million USD, reflecting ongoing investment in physical infrastructure.
Deferred Tax and Other Assets: Deferred income taxes have experienced a marked increase, rising from 793 million USD in March 2021 to 5,362 million USD by June 2026. This upward trend suggests a growing gap between accounting and tax treatments of assets and liabilities. Other non-current assets have remained relatively range-bound, fluctuating between 4,728 million USD and 7,403 million USD without a definitive long-term trend.

The overall shift in the balance sheet structure indicates a transition from an asset base heavily weighted toward acquired intangibles toward one with a higher proportion of tangible assets and deferred tax assets. While total asset value has decreased, the growth in receivables and PPE suggests continued operational scaling and capital investment.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?

Bristol-Myers Squibb Co. (NYSE:BMY)

Balance Sheet: AssetsQuarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data